Back

One-year maintenance of SGLT2 inhibitor therapy in octogenarians following acute heart failure with preserved or mildly reduced ejection fraction

11 May 2026 (13:00 - 14:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (4) Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Sandra Valdivielso

Hospital del Mar, Barcelona (Spain)

5 More presentations in this session

Presentation thumbnail
Clinical predictors of all-cause mortality and heart failure readmissions after intermittent levosimendan
Doctor R. Brandao (Amadora, PT)
Abstract Slides
Presentation thumbnail
Tafamidis non-responders in cardiac amyloidosis: clinical characterization of a real-world cohort
Doctor I. Cruz (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Effect of intravenous repletion of ferric hydroxide sucrose on the functional capacity of pacients with heart failure
Mrs A. Freitas (Curitiba, BR)
Abstract Slides
Presentation thumbnail
Predicted natriuretic output and cardiorenal phenotyping in hospitalised heart failure
Doctor S. Singh (Hartford, US)
Abstract Slides
Presentation thumbnail
Clinical profile, treatment selection, and early outcomes with TTR stabilizers to treat patients with transthyretin cardiac amyloidosis: a real-world study
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (4)

The Event

Event poster

Heart Failure 2026

11 May 2026 13:00 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Webinar
MRAs in heart failure: what's old is new again
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources